Enjoy the videos and music that you love, upload original content and share it all with friends, family and the world on YouTube.
🧪Don't miss this webinar by Dr. @rgergom.bsky.social (#IRBBarcelona-#Inbiomotion) that explores the biology & mechanism of action of the MAF gene, shedding light on its significant impact on patient outcomes.
@sourcebioscience.bsky.social
https://youtu.be/M7bvPjPQCq0?feature=shared
#BreastCancer
12.03.2025 10:02 — 👍 7 🔁 2 💬 0 📌 0
📌 MetEND: Descodificando las dependencias entre la #metástasis y la vasculatura.
El proyecto coordinado por el Dr. @rgergom.bsky.social pretende desarrollar nuevas opciones para el tratamiento del #CáncerdeMama metastásico, para lo que estudiará la relación entre la metástasis y la vascularización.
24.02.2025 12:25 — 👍 4 🔁 1 💬 1 📌 0
💬Mesa Redonda: Presente y Futuro del #CáncerDeMama
🗣️Dr. @rgergom.bsky.social (@irbbarcelona.org)
🗣️Dr. César Serrano (Hospital Vall d'Hebron-@vhio.bsky.social)
🗣️Carme Segura, paciente cáncer de mama
🎙️Modera: Michele Catanzaro
🗓️Miérc, 5 de febrero
🕡 18:30-20:00h
📍@iec.cat
🔗 https://bit.ly/3Wx0Fw5
30.01.2025 10:02 — 👍 2 🔁 1 💬 0 📌 0
Toxicity and costs of cancer treatment reduced by deferring CDK4/6 inhibitor use
No difference in survival outcomes between use of CDK4/6 inhibitors as first- or second-line treatment in metastatic breast cancer.
Exciting news in cancer therapy! The order of drugs impacts the duration of treatment, toxicity, and economic cost. A necessary example of how relevant academic, self-funded trials are!!
Breast #cancer #oncosky #oncsky #medsky 🧪 @natureportfolio.bsky.social www.nature.com/articles/d41...
27.11.2024 19:22 — 👍 56 🔁 14 💬 1 📌 3
🔵 The #IRBBarcelona Growth Control & #Cancer #Metastasis lab, led by @rgergom.bsky.social is offering two 3-year #PhD #fellowships in the framework of the Adaptmet Project for young scientists community who wish to undertake a doctoral degree in #biomedicine.
Read more here ➡️ shorturl.at/MDX95
26.11.2024 11:40 — 👍 4 🔁 3 💬 0 📌 0
Terrific talk by @mmalumbres.bsky.social !! at the biomed conference in barcelona
18.11.2024 11:26 — 👍 4 🔁 1 💬 0 📌 0
Looking forward to it
18.11.2024 09:12 — 👍 0 🔁 0 💬 0 📌 0
Let’s get started: BioMed Conference on “Mechanisms of resistance in cancer”. Francesc Posas, director of the IRB Barcelona, introducing the event! #oncosky 🧪
18.11.2024 08:05 — 👍 8 🔁 2 💬 2 📌 0
Just one day left for the #BarcelonaBiomed Conference "Molecular Determinants of #Cancer Therapy Resistance"!
🗓️ 18-20 Nov, 2024 #Barcelona
🤝 Angel R Nebreda (#IRB), Clare Isake (ICR_London) & @mmalumbres.bsky.social (VHIO), with @batllelab.bsky.social and a long list of speakers.
➡️bit.ly/4dBTSYI
17.11.2024 08:19 — 👍 26 🔁 9 💬 0 📌 1
what a squad😎
15.11.2024 12:54 — 👍 1 🔁 0 💬 0 📌 0
Cancer cell biologists in the 2024 meeting of the Spanish Association of Cancer Research (ASEICA) in beautiful Zaragoza.. waiting for you guys here in @bsky.app
15.11.2024 03:18 — 👍 8 🔁 1 💬 1 📌 0
Thanks @mmalumbres.bsky.social 😊
15.11.2024 12:24 — 👍 1 🔁 0 💬 0 📌 0
Very important
15.11.2024 12:23 — 👍 0 🔁 0 💬 0 📌 0
Historical alliance between Spanish associations against #cancer… ASEICA and AECC ContraCancer… we need you in @bsky.app
15.11.2024 12:04 — 👍 7 🔁 3 💬 1 📌 1
Publishing the latest advances across all areas of cancer research and oncology. Part of @natureportfolio.nature.com
🌐 www.nature.com/natcancer/
📍New York, London, Berlin and Heidelberg
PhD student | interested in metastasis & TME |UniTO/ DKFZ
Group Leader at @irbbarcelona.org
Mitochondrial Biology and Tissue Regeneration @mitotherapx-lab.bsky.social
Junior Leader Fellow @caixaresearch.bsky.social. Former postdoc at Simon Lab @ox.ac.uk, PhD at @genoxphos.bsky.social
Explico coses de salut a TV3
IKERBASQUE Research Professor at Biogipuzkoa HRI | Leading the group Bioengineering in Regeneration & Cancer (www.cipitrialab.com) | Trained at @MpiciPotsdam, @ChariteBerlin, @QUT | #Biomaterials, #TissueEngineering, #PhysicalScienceCancer
Bloomberg Distinguished Professor of Tumor Microenvironment. Johns Hopkins University School of Medicine.
The Metastasis Research Society (MRS) is dedicated to supporting progressive metastatic cancer research with the goal of improving treatments and patient lives.
http://www.metastasis-research.org
Group Leader of the Microenviroment and Metastasis Laboratory at CNB, Madrid, Spain.
Leukemia and Immuno-Oncology Group at the Josep Carreras Leukemia Research Institute and the Catalan Institute of Oncology (ProCURE)
Passionate scientist, runner, basket. Group leader at #IRBBarcelona | Targeted protein degradation | Chemical biology
Ex NY Times, now author of Substack Paul Krugman. Nobel laureate and, according to Donald Trump, "Deranged BUM"
Group Leader at @irbbarcelona.bsky.social | Postdoc @mskcancercenter.bsky.social, PhD @cniostopcancer.bsky.social | Cancer origins & context | Imagine Observe Perturb I 🌍 🎼 🔬
Scientific Strategy at VHIO & CancerCoreEurope | Science Communication at UNAV & UAB | Former Nature Medicine editor & cancer researcher
Research Associate at the @BatlleLab @ IRBBarcelona. We investigate metastatic colorectal cancer. Personal account.
Biochemist, with extensive experience in cancer research and biomarker strategy/discovery in both the pharmaceutical and academic sectors. Opinions are on my own.
Professor at University of Heidelberg and Head of Division of Molecular Thoracic Oncology at DKFZ. Passionate about lung cancer research.
We work on minimal residual disease and metastasis by colorectal cancer from the perspective of cancer stem cells and their interaction with the tumor microenvironment.
@IRBBarcelona,bsky.social
Professional #microtubule organizers and #centrosome deconstructors
@irbbarcelona.bsky.social